Copyright Reports & Markets. All rights reserved.

Global Laparoscopic Tumor Ablation Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Laparoscopic Tumor Ablation Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Laparoscopic Tumor Ablation by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Laparoscopic Tumor Ablation by Country/Region, 2017, 2022 & 2028
  • 2.2 Laparoscopic Tumor Ablation Segment by Type
    • 2.2.1 Microwave Ablation
    • 2.2.2 Radiofrequency (RF) Ablation
    • 2.2.3 Chemical Ablation
    • 2.2.4 Cryotherapy
    • 2.2.5 Others
  • 2.3 Laparoscopic Tumor Ablation Sales by Type
    • 2.3.1 Global Laparoscopic Tumor Ablation Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Laparoscopic Tumor Ablation Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Laparoscopic Tumor Ablation Sale Price by Type (2017-2022)
  • 2.4 Laparoscopic Tumor Ablation Segment by Application
    • 2.4.1 Orthopedic
    • 2.4.2 Lung
    • 2.4.3 Liver
    • 2.4.4 Others
  • 2.5 Laparoscopic Tumor Ablation Sales by Application
    • 2.5.1 Global Laparoscopic Tumor Ablation Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Laparoscopic Tumor Ablation Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Laparoscopic Tumor Ablation Sale Price by Application (2017-2022)

3 Global Laparoscopic Tumor Ablation by Company

  • 3.1 Global Laparoscopic Tumor Ablation Breakdown Data by Company
    • 3.1.1 Global Laparoscopic Tumor Ablation Annual Sales by Company (2020-2022)
    • 3.1.2 Global Laparoscopic Tumor Ablation Sales Market Share by Company (2020-2022)
  • 3.2 Global Laparoscopic Tumor Ablation Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Laparoscopic Tumor Ablation Revenue by Company (2020-2022)
    • 3.2.2 Global Laparoscopic Tumor Ablation Revenue Market Share by Company (2020-2022)
  • 3.3 Global Laparoscopic Tumor Ablation Sale Price by Company
  • 3.4 Key Manufacturers Laparoscopic Tumor Ablation Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Laparoscopic Tumor Ablation Product Location Distribution
    • 3.4.2 Players Laparoscopic Tumor Ablation Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Laparoscopic Tumor Ablation by Geographic Region

  • 4.1 World Historic Laparoscopic Tumor Ablation Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Laparoscopic Tumor Ablation Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Laparoscopic Tumor Ablation Annual Revenue by Geographic Region
  • 4.2 World Historic Laparoscopic Tumor Ablation Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Laparoscopic Tumor Ablation Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Laparoscopic Tumor Ablation Annual Revenue by Country/Region
  • 4.3 Americas Laparoscopic Tumor Ablation Sales Growth
  • 4.4 APAC Laparoscopic Tumor Ablation Sales Growth
  • 4.5 Europe Laparoscopic Tumor Ablation Sales Growth
  • 4.6 Middle East & Africa Laparoscopic Tumor Ablation Sales Growth

5 Americas

  • 5.1 Americas Laparoscopic Tumor Ablation Sales by Country
    • 5.1.1 Americas Laparoscopic Tumor Ablation Sales by Country (2017-2022)
    • 5.1.2 Americas Laparoscopic Tumor Ablation Revenue by Country (2017-2022)
  • 5.2 Americas Laparoscopic Tumor Ablation Sales by Type
  • 5.3 Americas Laparoscopic Tumor Ablation Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Laparoscopic Tumor Ablation Sales by Region
    • 6.1.1 APAC Laparoscopic Tumor Ablation Sales by Region (2017-2022)
    • 6.1.2 APAC Laparoscopic Tumor Ablation Revenue by Region (2017-2022)
  • 6.2 APAC Laparoscopic Tumor Ablation Sales by Type
  • 6.3 APAC Laparoscopic Tumor Ablation Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Laparoscopic Tumor Ablation by Country
    • 7.1.1 Europe Laparoscopic Tumor Ablation Sales by Country (2017-2022)
    • 7.1.2 Europe Laparoscopic Tumor Ablation Revenue by Country (2017-2022)
  • 7.2 Europe Laparoscopic Tumor Ablation Sales by Type
  • 7.3 Europe Laparoscopic Tumor Ablation Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Laparoscopic Tumor Ablation by Country
    • 8.1.1 Middle East & Africa Laparoscopic Tumor Ablation Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Laparoscopic Tumor Ablation Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Laparoscopic Tumor Ablation Sales by Type
  • 8.3 Middle East & Africa Laparoscopic Tumor Ablation Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Laparoscopic Tumor Ablation
  • 10.3 Manufacturing Process Analysis of Laparoscopic Tumor Ablation
  • 10.4 Industry Chain Structure of Laparoscopic Tumor Ablation

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Laparoscopic Tumor Ablation Distributors
  • 11.3 Laparoscopic Tumor Ablation Customer

12 World Forecast Review for Laparoscopic Tumor Ablation by Geographic Region

  • 12.1 Global Laparoscopic Tumor Ablation Market Size Forecast by Region
    • 12.1.1 Global Laparoscopic Tumor Ablation Forecast by Region (2023-2028)
    • 12.1.2 Global Laparoscopic Tumor Ablation Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Laparoscopic Tumor Ablation Forecast by Type
  • 12.7 Global Laparoscopic Tumor Ablation Forecast by Application

13 Key Players Analysis

  • 13.1 Boston Scientific Corporation
    • 13.1.1 Boston Scientific Corporation Company Information
    • 13.1.2 Boston Scientific Corporation Laparoscopic Tumor Ablation Product Offered
    • 13.1.3 Boston Scientific Corporation Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Boston Scientific Corporation Main Business Overview
    • 13.1.5 Boston Scientific Corporation Latest Developments
  • 13.2 EDAP TMS
    • 13.2.1 EDAP TMS Company Information
    • 13.2.2 EDAP TMS Laparoscopic Tumor Ablation Product Offered
    • 13.2.3 EDAP TMS Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 EDAP TMS Main Business Overview
    • 13.2.5 EDAP TMS Latest Developments
  • 13.3 Medtronic
    • 13.3.1 Medtronic Company Information
    • 13.3.2 Medtronic Laparoscopic Tumor Ablation Product Offered
    • 13.3.3 Medtronic Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Medtronic Main Business Overview
    • 13.3.5 Medtronic Latest Developments
  • 13.4 Misonix
    • 13.4.1 Misonix Company Information
    • 13.4.2 Misonix Laparoscopic Tumor Ablation Product Offered
    • 13.4.3 Misonix Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Misonix Main Business Overview
    • 13.4.5 Misonix Latest Developments
  • 13.5 Sonacare Medical
    • 13.5.1 Sonacare Medical Company Information
    • 13.5.2 Sonacare Medical Laparoscopic Tumor Ablation Product Offered
    • 13.5.3 Sonacare Medical Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Sonacare Medical Main Business Overview
    • 13.5.5 Sonacare Medical Latest Developments
  • 13.6 AngioDynamics
    • 13.6.1 AngioDynamics Company Information
    • 13.6.2 AngioDynamics Laparoscopic Tumor Ablation Product Offered
    • 13.6.3 AngioDynamics Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 AngioDynamics Main Business Overview
    • 13.6.5 AngioDynamics Latest Developments
  • 13.7 BTG International
    • 13.7.1 BTG International Company Information
    • 13.7.2 BTG International Laparoscopic Tumor Ablation Product Offered
    • 13.7.3 BTG International Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 BTG International Main Business Overview
    • 13.7.5 BTG International Latest Developments
  • 13.8 HealthTronics
    • 13.8.1 HealthTronics Company Information
    • 13.8.2 HealthTronics Laparoscopic Tumor Ablation Product Offered
    • 13.8.3 HealthTronics Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 HealthTronics Main Business Overview
    • 13.8.5 HealthTronics Latest Developments
  • 13.9 Mermaid Medical
    • 13.9.1 Mermaid Medical Company Information
    • 13.9.2 Mermaid Medical Laparoscopic Tumor Ablation Product Offered
    • 13.9.3 Mermaid Medical Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Mermaid Medical Main Business Overview
    • 13.9.5 Mermaid Medical Latest Developments
  • 13.10 NeuWave Medical
    • 13.10.1 NeuWave Medical Company Information
    • 13.10.2 NeuWave Medical Laparoscopic Tumor Ablation Product Offered
    • 13.10.3 NeuWave Medical Laparoscopic Tumor Ablation Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 NeuWave Medical Main Business Overview
    • 13.10.5 NeuWave Medical Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Laparoscopic Tumor Ablation will have significant change from previous year. According to our (LP Information) latest study, the global Laparoscopic Tumor Ablation market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Laparoscopic Tumor Ablation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Laparoscopic Tumor Ablation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Laparoscopic Tumor Ablation market, reaching US$ million by the year 2028. As for the Europe Laparoscopic Tumor Ablation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Laparoscopic Tumor Ablation players cover Boston Scientific Corporation, EDAP TMS, Medtronic, and Misonix, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Laparoscopic Tumor Ablation market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Microwave Ablation
Radiofrequency (RF) Ablation
Chemical Ablation
Cryotherapy
Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Orthopedic
Lung
Liver
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boston Scientific Corporation
EDAP TMS
Medtronic
Misonix
Sonacare Medical
AngioDynamics
BTG International
HealthTronics
Mermaid Medical
NeuWave Medical
Buy now